Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by BorrowedClotheson Sep 17, 2018 5:08pm
219 Views
Post# 28635371

ACB Financials 9/30/2018

ACB Financials 9/30/2018Coca Cola news, speculation, no real deal, still a company with 1 billion shares of dilutional hell. Anyway. Sorry. Negative nancy here, I'm still happy about the green day FINALLY ACB YOU TEASING HOE. *tucks shirt back into pants* - *adjusts tie* - *Clears throat*.... My questions is below:

ACB Q4 financials are due on Sept 30th.
Will this weight negatively on the stock price? I just feel like for meeeeeee. The SP will drop significantly considering the amount of money they've spent acquiring other companies & getting their operation moving forward with the looming legalization date. That being said, which financial results do you think will finally push the company into a forward-momentum no-looking-back kind of deal? Q1 '19/Q2 '19/Q3 '19? etc.....

Regards
Bullboard Posts